Release Date: 16/08/10 08:26 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 362.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%